Approval · Notice of Compliance 29969 · 2023
PHEBURANE: Notice of Compliance 29969
Issued January 25, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29969
- Date
- January 25, 2023
- Company
- Medunik CanadaBlainville, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product tests and acceptance criteria
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PHEBURANE | Not yet assigned | — |
Medicinal ingredients
- SODIUM PHENYLBUTYRATE 483 MG per G